Simon Bennett

Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA.

Oxford BioTherapeutics Ltd. develops antibody-based medicines for oncology. The firm offers antibody-based cancer drugs with integrated diagnostics against novel targets. The company was founded by Christian Rohlff in 2003 and is headquartered in Abingdon, the United Kingdom.

Dana-Farber Cancer Institute, Inc. provides treatment to cancer patients and also researches new cancer diagnostics, treatments, and preventions. The firm's patients receive treatment through its cancer centers operated with Brigham and Women's Hospital, Children's Hospital Boston, Massachusetts General Hospital, and Beth Israel Deaconess Medical Center. The company was founded by Sidney Farber in 1947 and is headquartered in Boston, MA.

The Brigham & Women's Hospital, Inc. provides health care services. The firm offers treatment for cancer, cardio vascular, neurosciences, orthopedic, arthritis, women's health and clinical services. The company was founded in 1980 and is headquartered in Boston, MA.

Idis Ltd. supplies pharmaceuticals and allied services to the healthcare industry. the company was founded by Crane Michael and Gould Amanda in 1987 and is headquartered in Weybridge, The united kingdom

F-star Alpha Ltd. develops novel bispecific antibody products. It focuses on treatment of breast and gastric cancer among a population of HER2-positive patients who do not respond or become resistant to current therapies. The company was founded in October 2013 and is headquartered in Cambridge, the United Kingdom.

Genomics England Ltd. runs and delivers 100,000 genomes project. Its flagship project sequences 100,000 genomes from NHS patients with a rare disease and their families, and patients with cancer. The company was founded by Jeremy Hunt on July 5, 2013 and is headquartered in London, the United Kingdom.

Mustang Bidco Ltd. operates as an early stage company. The company is headquartered in Douglas, Isle of Man.

Levicept Ltd. develops a biological therapy for the treatment of osteoarthritis and chronic pain. Its treatments include p75NTR-Fc and LEVI-04. The company was founded by Simon Lempriere Westbrook on August 23, 2012 and is headquartered in Sandwich, the United Kingdom.

Part of Triley Bidco Ltd., Clinigen CTS Ltd. is a British company that provides investigator-initiated studies services to investigators, with managed regulatory pathways required for support of IIS & EAP programs. The company is based in Burton-On-Trent, UK and has more than 30 years ’ experience providing quicker and broader access to critical medicines in 130+ countries, pre- and post-launch. The company helps Pharmaceutical and Biotech companies grant access to unlicensed medicines around the globe. Clinigen's controlled drug handling services include five DEA registrations: manufacturer, importer, exporter, distributor, and retail pharmacy services. The company also offers a Patient Advocate Fellowship.

Part of Triley Bidco Ltd., Clinigen Healthcare Ltd. is a British company founded in 2007 that has more than 30 years of experience providing quicker and broader access to critical medicines in 130+ countries, pre- and post-launch. The company is based in Burton-on-Trent, UK. The company's investigator-initiated studies services provide smart solutions to investigators, with managed regulatory pathways required for support of IIS & EAP programs. Through the Clinigen Management Access, patient and healthcare professionals are granted access to the medicines they need.

Keats Healthcare Ltd. engages in manufacturing and processing of drugs in pharmaceutical preparations for human or veterinary use. The company was founded on May 15, 2008 and is headquartered in Burton-On-Trent, the United Kingdom.

Part of Iovance Biotherapeutics, Inc., Clinigen SP Ltd. is a British pharmaceutical company that manufactures and sells pharmaceutical products. The company is based in Burton-On-Trent, UK. The company was founded in 2013. Clinigen was acquired by Iovance Biotherapeutics, Inc. from Clinigen Holdings Ltd. on May 18, 2023 for $264.04 million.

CANbridge Life Sciences Ltd. produces biopharmaceutical products. It engages in the research and development of therapeutic drug treatment for critical medical condition. The company was founded by James Xue on June 12, 2012 and is headquartered in Chaoyang, China.

Tmunity Therapeutics, Inc. develops novel products that free the immunological potential of T cells to treat disease indications. It develops novel T Cell Receptor (TCR) engineered T cells, regulatory T cells (Treg), and universal engineered T cell platforms. The company was founded by Carl H. June, Anne Chew, Bruce Levine, Yangbing Zhao, James L. Riley and Bruce Blazar and is headquartered in Philadelphia, PA.

F-Star Beta Ltd. is a biopharmaceutical company that focused in the development of oncology and immune-oncology products. The company was founded on October 14, 2014 and is headquartered in Cambridge, the United Kingdom.

Avacta Life Sciences Ltd. provides powerful reagents for research and diagnostics. The company is headquartered in Wetherby, the United Kingdom.

C7 Health Ltd. provides software services to healthcare industries. The company was founded by Philip John Webb in April 2018 and is headquartered in London, the United Kingdom.

Ochre Bio Ltd. is a biotechnology company based in Headington, UK. Ochre Bio is focused on developing RNA medicines for chronic liver diseases. The British company uses deep phenotyping, precision RNA medicine, and testing in live human donor livers to develop therapies for important liver health challenges. The company's goal is to develop therapies that increase donor liver supply and reduce cirrhosis complications. The company was founded by Quin Wills and the CEO is Jack O'Meara.

Part of Triley Bidco Ltd., Clinigen Holdings Ltd. develops pharmaceutical products. The company is based in Burton-on-Trent, UK. Clinigen Holdings was founded in 2017.

Part of Immunocore Holdings Plc, Immunocore Ltd. is a British commercial-stage biotechnology company that develops and commercializes transformative medicines to address unmet needs in cancer, infection, and autoimmune disease. The company is based in Oxon, UK. The company has a robust pipeline of wholly owned and partnered programs to address a broad spectrum of disease indications, built on their proprietary soluble TCR bi-specific Immtac® platform. The company was founded in 2007, and the CEO is Bahija Jallal.

Tessellate Bio BV is a Dutch preclinical stage biotechnology company that focuses on discovering and developing precision oncology medicines. The company is based in Naarden, the Netherlands. The company's mission is to turn cancer patients into cancer survivors by targeting unexplored or difficult to drug pathways beyond HRD. The company is also developing companion diagnostics, including a potentially diagnostic to detect ALT positive cancers. Led by an experienced team of drug hunters, Tessellate Bio is building a pipeline of first-in-class medicines based on cutting-edge research. The company was founded by Hilda A. Pickett and the CEO is Andree Blaukat.

Part of Triley Bidco Ltd., Idis Group Holdings Ltd. is a holding British company. The company is based in Burton-on-Trent, UK. Founded in 2005, Idis Group Holdings operates as a holding company.

Part of Triley Bidco Ltd., Idis Group Ltd. functions as an investment holding British company. The company is based in Burton-On-Trent, UK.